Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

DRIESSENS

Showing results (351-360 of 379) with videos related to

Pageof 38
Sort By:
Circulation|November 8, 2006
Endoglin has a crucial role in blood cell-mediated vascular repairLinda W van Laake, Sander van den Driesche, Simone Post, et al.
Blood Reviews|November 14, 2019
Maternal and neonatal bleeding complications in relation to peripartum management in women with Von Willebrand disease: A systematic reviewM C Punt, M L Waning, E P Mauser-Bunschoten, et al.
Research and Practice in Thrombosis and Haemostasis|April 10, 2025
Real-world bleeding rates on emicizumab: the value of using nationwide digital treatment diary data in clinical researchMartijn R Brands, Elisabeth M Taal, Martijn Oude Voshaar, et al.
Blood Reviews|March 29, 2021
Maternal and neonatal bleeding complications in relation to peripartum management in hemophilia carriers: A systematic reviewM C Punt, M L Waning, E P Mauser-Bunschoten, et al.
The Journal of Clinical Investigation|December 13, 2022
TIGIT inhibition and lenalidomide synergistically promote antimyeloma immune responses after stem cell transplantation in miceSimone A Minnie, Olivia G Waltner, Kathleen S Ensbey, et al.
BMJ Open|April 25, 2019
Desmopressin treatment combined with clotting factor VIII concentrates in patients with non-severe haemophilia A: protocol for a multicentre single-armed trial, the DAVID studyLisette M Schütte, Marjon H Cnossen, Reinier M van Hest, et al.
Research and Practice in Thrombosis and Haemostasis|September 2, 2022
Socioeconomic participation of persons with hemophilia: Results from the sixth hemophilia in the Netherlands studyErna C van Balen, Shermarke Hassan, Cees Smit, et al.
Research and Practice in Thrombosis and Haemostasis|August 21, 2023
Desmopressin in nonsevere hemophilia A: patient perspectives on use and efficacyLorenzo G R Romano, Lize F D van Vulpen, Paul L den Exter, et al.
Thrombosis and Haemostasis|June 12, 2015
The "OPTI-CLOT" trial. A randomised controlled trial on periOperative PharmacokineTIc-guided dosing of CLOTting factor concentrate in haemophilia AHendrika C A M Hazendonk, Iris van Moort, Karin Fijnvandraat, et al.
Journal of Thrombosis and Haemostasis : JTH|June 12, 2021
Health and treatment outcomes of patients with hemophilia in the Netherlands, 1972-2019Shermarke Hassan, Erna C van Balen, Cees Smit, et al.
Pageof 38

Showing results (351-360 of 379) with videos related to

Sort By:
Pageof 38
Circulation|November 8, 2006
Endoglin has a crucial role in blood cell-mediated vascular repairLinda W van Laake, Sander van den Driesche, Simone Post, et al.
Blood Reviews|November 14, 2019
Maternal and neonatal bleeding complications in relation to peripartum management in women with Von Willebrand disease: A systematic reviewM C Punt, M L Waning, E P Mauser-Bunschoten, et al.
Research and Practice in Thrombosis and Haemostasis|April 10, 2025
Real-world bleeding rates on emicizumab: the value of using nationwide digital treatment diary data in clinical researchMartijn R Brands, Elisabeth M Taal, Martijn Oude Voshaar, et al.
Blood Reviews|March 29, 2021
Maternal and neonatal bleeding complications in relation to peripartum management in hemophilia carriers: A systematic reviewM C Punt, M L Waning, E P Mauser-Bunschoten, et al.
The Journal of Clinical Investigation|December 13, 2022
TIGIT inhibition and lenalidomide synergistically promote antimyeloma immune responses after stem cell transplantation in miceSimone A Minnie, Olivia G Waltner, Kathleen S Ensbey, et al.
BMJ Open|April 25, 2019
Desmopressin treatment combined with clotting factor VIII concentrates in patients with non-severe haemophilia A: protocol for a multicentre single-armed trial, the DAVID studyLisette M Schütte, Marjon H Cnossen, Reinier M van Hest, et al.
Research and Practice in Thrombosis and Haemostasis|September 2, 2022
Socioeconomic participation of persons with hemophilia: Results from the sixth hemophilia in the Netherlands studyErna C van Balen, Shermarke Hassan, Cees Smit, et al.
Research and Practice in Thrombosis and Haemostasis|August 21, 2023
Desmopressin in nonsevere hemophilia A: patient perspectives on use and efficacyLorenzo G R Romano, Lize F D van Vulpen, Paul L den Exter, et al.
Thrombosis and Haemostasis|June 12, 2015
The "OPTI-CLOT" trial. A randomised controlled trial on periOperative PharmacokineTIc-guided dosing of CLOTting factor concentrate in haemophilia AHendrika C A M Hazendonk, Iris van Moort, Karin Fijnvandraat, et al.
Journal of Thrombosis and Haemostasis : JTH|June 12, 2021
Health and treatment outcomes of patients with hemophilia in the Netherlands, 1972-2019Shermarke Hassan, Erna C van Balen, Cees Smit, et al.
Pageof 38